drugset / Trial / NCT06609512

A Clinical Study of Enlicitide and the Effect of Food in Healthy Adult Participants (MK-0616-033)

NCT06609512

Phase 1 Completed 20 enrolled Merck Sharp & Dohme LLC
RandomizedCrossoverOpen-labelBasic science

Summary

The goal of the study is to learn what happens to enlicitide decanoate in a healthy person's body over time when taken on an empty stomach or with food. Researchers will compare what happens to enlicitide in a healthy person's body over time when enlicitide is taken with or without food. Enlicitide decanoate will be referred to as "enlicitide" throughout.

Timeline

Start
2024-10-21
Primary completion
2025-01-13
Completion
2025-01-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Enlicitide Unknown Oral

Indications

No indication recorded.